National Organization for Rare Disorders Remarks before the FDA Endocrinologic and Metabolic Drugs Advisory Committee Silver Spring, Maryland November 19, 2013 Good afternoon. My name is Diane Edquist Dorman, Vice Presid - National Organization for Rare Disorders - Document - PDFSEARCH.IO

First Page	Meta Content
	National Organization for Rare Disorders Remarks before the FDA Endocrinologic and Metabolic Drugs Advisory Committee Silver Spring, Maryland November 19, 2013 Good afternoon. My name is Diane Edquist Dorman, Vice Presid Add to Reading List Document Date: 2013-11-22 12:36:21 Open Document File Size: 180,25 KB Share Result on Facebook Company BioMarin / / Country United States / / IndustryTerm biopharmaceutical / / MedicalCondition Rare disease / rare diseases / rare disorders / Syndrome / / MedicalTreatment alternative therapy / / Organization FDA / Advisory Committee / National Organization for Rare Disorders Comments / Endocrinologic and Metabolic Drugs Advisory Committee / National Organization for Rare Disorders / National Organization for Rare Disorders Remarks / / Person Diane Edquist Dorman / / Position Vice President for Public Policy / / SocialTag Rare diseases Drug discovery Orphan drug Pharmaceuticals policy Morquio syndrome Pharmaceutical industry BioMarin Pharmaceutical Mucopolysaccharidosis National Organization for Rare Disorders Health

National Organization for Rare Disorders Remarks before the FDA Endocrinologic and Metabolic Drugs Advisory Committee Silver Spring, Maryland November 19, 2013 Good afternoon. My name is Diane Edquist Dorman, Vice PresidAdd to Reading List